Radiotherapy in Cutaneous B-Cell Lymphomas Treatment: Report of Three CasesMontserrat Molgó1, Josefina Rodríguez2, Camila Arriagada2*, Eugenio Vines3, Félix Fich1, Katherine Droppelmann1 and Sergio González4
- *Corresponding Author:
- Camila Arriagada
Resident of Dermatology, School of Medicine
Pontificia Universidad Católica de Chile, Chile
E-mail: [email protected]
Received date: October 28, 2015 Accepted date: December 07 2015 Published date: December 12, 2015
Citation: Montserrat Molgó, Josefina Rodríguez, Camila Arriagada, Eugenio Vines, Félix Fich, et al. (2015) Radiotherapy in Cutaneous B-Cell Lymphomas Treatment: Report of Three Cases. J Leuk 3:197. doi:10.4172/2329-6917.1000197
Copyright: © 2015 Montserrat M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Introduction: Primary cutaneous lymphomas (PCL) are a heterogeneous group of extra nodal non-Hodgkin lymphomas defined as malignant tumor derived from B, T or natural killer cells. Primary cutaneous follicle centre lymphoma (PCFCL), represents the most common type of primary cutaneous B- Cell Lymphomas.
Case Report: We present the case of three female patients with facial PCFCL, all of them with excellent respond to radiotherapy.
Discussion: Multiple treatments for PCFCL have been described, including systemic or intralesional Rituximab, surgery or radiotherapy. We present these 3 cases of PCFLC treated with radiotherapy in our service, because of the excellent response, confirming radiotherapy as a therapeutic alternative.